TCL Archive VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial May 30, 2014
TCL Archive Funding Opportunities: RFAs Available: NCI Challenge For Tumor Classification February 5, 1999
TCL Archive Studies Are Demonstrating Effectiveness Of Drug Combinations As Adjuvant Therapy; NCI Will Support New Clinical Trials April 12, 1974
TCL Archive New Technology May Enable Therapy Tailored To Patient’s Predicted Response April 26, 2002
TCL Archive In Brief: New Mount Sinai Cancer Center Gets $7 Million; Jules Harris Named Rush Cancer Center Director July 25, 1986
